Table 1 Distribution of malignancies among patients before and after categorization
Type of malignancy | Number of patients | Tumor group after categorization | Number of patients |
|---|---|---|---|
Ovarian CA | 27 (22.3%) | AT/Perit. CA | 38 (31.4%) |
Peritoneal CA | 6 (5%) | ||
Immature ovarian teratoma | 2 (1.7%) | ||
Ovarian granulosa cell tumor | 1 (0.8%) | ||
Fallopian tube CA | 1 (0.8%) | ||
Dysgerminoma | 1 (0.8%) | ||
Endometrial CA | 22 (18.2%) | CU/US | 24 (19.8%) |
MMMT | 1 (0.8%) | ||
Uterine sarcoma | 1 (0.8%) | ||
Vulvar | 24 (19.8%) | Vulvar | 24 (19.8%) |
Vaginal | 4 (3.3%) | Vaginal | 4 (3.3%) |
Cervical | 31 (25.6%) | Cervical | 31 (25.6%) |